Application
一种有效的BET抑制剂。
Y06036 is a potent BET Inhibitors for Potential Treatment of Castration-Resistant Prostate Cancer (CRPC). Y06036 bounds to the BRD4(1) bromodomain with Kd values of 82 nM. Y06036 also exhibited high selectivity over other non-BET subfamily members. Y06036 potently inhibited cell growth, colony formation, and the expression of AR, AR regulated genes, and MYC in prostate cancer cell lines. Y06036 also demonstrated therapeutic effects in a C4-2B CRPC xenograft tumor model in mice。
Y06036是一种有效的BET抑制剂,可潜在治疗去势抵抗性前列腺癌(CRPC)。 Y06036绑定到BRD4(1)溴结构域,其Kd值为82 nM。 Y06036还显示出比其他非BET亚家族成员更高的选择性。 Y06036有效抑制前列腺癌细胞系中的细胞生长,集落形成以及AR,AR调控基因和MYC的表达。 Y06036在C4-2B CRPC异种移植小鼠模型中也显示出治疗作用。
安全信息
RIDADR NONH for all modes of transport